An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants

Signal Transduct Target Ther. 2022 Sep 17;7(1):327. doi: 10.1038/s41392-022-01185-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / genetics
  • Vaccines*

Substances

  • Spike Glycoprotein, Coronavirus
  • Vaccines
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants